Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

They showed that lung vascular disease is preceded by inflammation. Later, they found that specific subtypes of macrophages ...

naked-eye examination of the lung slices and of the specimen arteriograms pointed to the widespread distribution of the vascular changes. A similar increase of vessels was noted in 2 upper-lobe ...

New research reveals that severe COVID-19 pneumonia can cause lasting lung damage, primarily due to impaired pulmonary ...

If vaping is significantly affecting someone’s vascular health, e-cigarette users could then see increased heart attacks, strokes or blood flow issues, Rizzo said. “At the Lung Association ...

Swedish researchers have identified genetic variants that increase the risk of atherosclerosis. The aim is for these new ...

The new drug sotatercept stops the remodelling of the pulmonary vessels and even helps patients with advanced pulmonary arterial hypertension (PAH) who have not yet been treated.

Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among ...

Researchers developed a tool for predicting the prognosis of people with chronic lung disease-related pulmonary hypertension.

By 2023, approximately 1 in 5 patients with non-small cell lung cancer or metastatic colorectal cancer were treated with a bevacizumab biosimilar.